This study was undertaken to determine whether sialic acid removal alters the catabolism of low density lipoprotein in humans. Human low density lipoproteins labeled in vitro with 125I were incubated in the presence (termed desialylated) or absence (sialylated) of neuraminidase. The treatment with neuraminidase from Clostridium perfringens removed 90% of the sialic acid residues which did not change the chemical composition of the lipoproteins. Sialylated or desialylated LDL were injected intravenously into normal human subjects. The mathematical analysis of the plasma radioactivity decay curves (followed for 220 h) of desialylated low density lipoproteins, when compared with sialylated LDL, showed a shorter mean transit time (51 h vs 60 h)...
The serum samples were obtained from the rnaternal and fetal pairs and various cancer patients. Th...
This study was designed to investigate the mechanism(s) underlying the hypercatabolism of high densi...
International audienceAIMS : Human plasma lipoproteins are known to contain various glycan structure...
AbstractThe role of oxidatively modified LDL in the pathogenesis of atherosclerosis has been well do...
Atherosclerosis and related cardiovascular disorders remain the leading global cause of morbidity an...
Aim: This study was undertaken to investigate the physicochemical properties of modified low density...
olism occurs by LDL receptor-dependent and LDL receptor-independent pathways. We have shown pre-viou...
Atherosclerosis is one of the leading causes of death in developed and developing countries. The ath...
AbstractThe degradation of human low density lipoprotein (LDL) was analyzed in fasted rats treated f...
The mechanism of hepatic catabolism of human low density lipoproteins (LDL) by human-derived hepatom...
To define the roles, In vivo, of hepatic triglyceride lipase and lipoprotein lipase in the catabolis...
Background Chronic vascular disease atherosclerosis starts with an uptake of atherogenic modified lo...
Emile R Zakiev,1 Igor A Sobenin,1,2 Vasily N Sukhorukov,1 Veronika A Myasoedova,1 Ekaterina A Ivanov...
AbstractThe sites of degradation of human low density lipoprotein (LDL), are analyzed using the nove...
Low density lipoproteins (LDL) in patients with coronary atherosclerosis have a substantially lower ...
The serum samples were obtained from the rnaternal and fetal pairs and various cancer patients. Th...
This study was designed to investigate the mechanism(s) underlying the hypercatabolism of high densi...
International audienceAIMS : Human plasma lipoproteins are known to contain various glycan structure...
AbstractThe role of oxidatively modified LDL in the pathogenesis of atherosclerosis has been well do...
Atherosclerosis and related cardiovascular disorders remain the leading global cause of morbidity an...
Aim: This study was undertaken to investigate the physicochemical properties of modified low density...
olism occurs by LDL receptor-dependent and LDL receptor-independent pathways. We have shown pre-viou...
Atherosclerosis is one of the leading causes of death in developed and developing countries. The ath...
AbstractThe degradation of human low density lipoprotein (LDL) was analyzed in fasted rats treated f...
The mechanism of hepatic catabolism of human low density lipoproteins (LDL) by human-derived hepatom...
To define the roles, In vivo, of hepatic triglyceride lipase and lipoprotein lipase in the catabolis...
Background Chronic vascular disease atherosclerosis starts with an uptake of atherogenic modified lo...
Emile R Zakiev,1 Igor A Sobenin,1,2 Vasily N Sukhorukov,1 Veronika A Myasoedova,1 Ekaterina A Ivanov...
AbstractThe sites of degradation of human low density lipoprotein (LDL), are analyzed using the nove...
Low density lipoproteins (LDL) in patients with coronary atherosclerosis have a substantially lower ...
The serum samples were obtained from the rnaternal and fetal pairs and various cancer patients. Th...
This study was designed to investigate the mechanism(s) underlying the hypercatabolism of high densi...
International audienceAIMS : Human plasma lipoproteins are known to contain various glycan structure...